EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AI-assessed sarcopenia as an independent predictor of neoadjuvant chemotherapy outcomes in muscle-invasive bladder cancer

Antonella Borrelli, Simone Novelli, Emanuele Messina, Ludovica Laschena, Ailin Dehghanpour, Francesca Mezzapesa, Nicholas Landini, Giuseppe Simone, Maurizio Muscaritoli, Valeria Panebianco

La radiologia medica · 31.03.2026 · 131 (7) · 1217-1227

DOI: 10.1007/s11547-026-02203-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift La radiologia medica, online erschienen am 31.03.2026. Verfasst von Antonella Borrelli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiological Sciences, Oncology and Pathology, Sapienza University, Sapienza/Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome…. Hauptthemen laut MEDLINE: Sarcopenia, Urinary Bladder Neoplasms, Neoadjuvant Therapy, Artificial Intelligence. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca, Università degli Studi di Roma La Sapienza.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Sarcopenia has already been widely investigated as a potential indicator of negative outcomes in oncology patients. Our aim was to evaluate the potential predictive role of sarcopenia assessed using an Artificial Intelligence-powered software in response to neoadjuvant chemotherapy (NAC) in patients with muscle-invasive bladder cancer (MIBC). Materials and methods In this single-centre retrospective study, we enrolled patients diagnosed with non-metastatic MIBC who underwent NAC and had available pre-treatment mpMRI of the bladder and baseline CT scan. The follow-up MRI assessment was performed using the NacVI-RADS algorithm to evaluate response to systematic therapy. AI-based software automatically calculated the skeletal muscle index (SMI) from CT images at the L3 vertebral level. Multivariate logistic regression analysis was performed to assess independent predictors of response to NAC, and a receiver operating characteristic (ROC) analysis was subsequently conducted to provide an additional level of statistical validation.

Results

Fifty-five patients were included (mean age: 67.2 years). Sarcopenia was identified in 36.4% of patients. Multivariate logistic regression revealed sarcopenia (OR: 9.08; 95% CI 1.32–61.92; p = 0.024), comorbidities (OR: 14.63; 95% CI 2.12–100.71; p = 0.006), and high NacVI-RADS scores (4–5) (OR = 2.13 95% CI 1.03–4.42; p = 0.042) as independent predictors of poor response to NAC. Receiver operating characteristic (ROC) curve analysis confirmed the high discriminative ability of SMI for predicting treatment response (AUC = 0.952).

Conclusion

Sarcopenia, assessed by AI-powered analysis, was negatively associated with tumor response following NAC in patients with MIBC. These findings support the integration of AI-driven sarcopenia evaluation into clinical staging workflows, enabling tailored nutritional interventions and improved patient stratification. Moreover, our study reinforces the prognostic value of the NacVI-RADS scoring system in predicting NAC outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaUrinary Bladder NeoplasmsNeoadjuvant TherapyArtificial IntelligenceHumansFemaleMaleRetrospective StudiesAgedTomography, X-Ray ComputedNeoplasm InvasivenessTreatment OutcomeMiddle AgedPredictive Value of TestsMagnetic Resonance Imaging

Stichwörter der Autor:innen

Artificial intelligenceBladder cancerComputed tomographyMagnetic resonanceOncologySarcopenia

Autor:innen und Institutionen

  • Department of Radiological Sciences, Oncology and Pathology, Sapienza University, Sapienza/Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy.
  • Department of Mechanical and Aerospace Engineering, Sapienza University of Rome, Rome, Italy.
  • Liver Failure Group, Institute for Liver and Digestive Health, UCL Medical School, Royal Free Hospital, London, UK.
  • Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
  • Department of Translational and Precision Medicine, Sapienza University of Rome, 00161, Rome, Italy.
  • Department of Radiological Sciences, Oncology and Pathology, Sapienza University, Sapienza/Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy. valeria.panebianco@gmail.com.

Förderung

  • Ministero dell'Università e della Ricerca
  • Università degli Studi di Roma La Sapienza

Zitieren

APA

Borrelli, A., Novelli, S., Messina, E., Laschena, L., Dehghanpour, A., Mezzapesa, F., Landini, N., Simone, G., Muscaritoli, M., & Panebianco, V. (2026). AI-assessed sarcopenia as an independent predictor of neoadjuvant chemotherapy outcomes in muscle-invasive bladder cancer. La radiologia medica, 131(7), 1217-1227. https://doi.org/10.1007/s11547-026-02203-2

Vancouver

Borrelli A, Novelli S, Messina E, Laschena L, Dehghanpour A, Mezzapesa F, et al. AI-assessed sarcopenia as an independent predictor of neoadjuvant chemotherapy outcomes in muscle-invasive bladder cancer. La radiologia medica. 2026;131(7):1217-1227. doi:10.1007/s11547-026-02203-2

BibTeX
@article{Borrelli2026,
  author = {Borrelli, Antonella and Novelli, Simone and Messina, Emanuele and Laschena, Ludovica and Dehghanpour, Ailin and Mezzapesa, Francesca and Landini, Nicholas and Simone, Giuseppe and Muscaritoli, Maurizio and Panebianco, Valeria},
  title = {AI-assessed sarcopenia as an independent predictor of neoadjuvant chemotherapy outcomes in muscle-invasive bladder cancer},
  journal = {La radiologia medica},
  year = {2026},
  volume = {131},
  number = {7},
  pages = {1217--1227},
  doi = {10.1007/s11547-026-02203-2}
}
Kostenlos starten →